{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:17:50Z","timestamp":1788959870503,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004442","name":"National Science Centre, Poland","doi-asserted-by":"publisher","award":["2017\/01\/X\/NZ3\/00519"],"award-info":[{"award-number":["2017\/01\/X\/NZ3\/00519"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.phymed.2019.152847","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T04:20:39Z","timestamp":1548908439000},"page":"152847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Suppression of autophagy enhances preferential toxicity of epothilone A and epothilone B in ovarian cancer cells"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4170-1693","authenticated-orcid":false,"given":"Aneta","family":"Rogalska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadiusz","family":"Gajek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Marczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2019.152847_bib0001","doi-asserted-by":"crossref","first-page":"e72162","DOI":"10.1371\/journal.pone.0072162","article-title":"Type-specific cell line models for type-specific ovarian cancer research","volume":"8","author":"Anglesio","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2019.152847_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103988","article-title":"Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes","volume":"9","author":"Beaufort","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2019.152847_bib0003","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5","article-title":"Molecular effects of paclitaxel: myths and reality (a critical review)","volume":"83","author":"Blagosklonny","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phymed.2019.152847_bib0004","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cellsig.2013.11.028","article-title":"The role of cell signalling in the crosstalk between autophagy and apoptosis","volume":"26","author":"Booth","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.phymed.2019.152847_bib0005","first-page":"943","article-title":"Evaluation of a tetrazolium-based semiautomated colorimetric assay\u2014assessment of radiosensitivity","volume":"47","author":"Carmichael","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2019.152847_bib0006","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41419-018-0866-5","article-title":"Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells","volume":"9","author":"Cristofani","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phymed.2019.152847_bib0007","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-2275(20)31588-1","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"42","author":"Dean","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phymed.2019.152847_bib0033","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cllc.2011.02.005","article-title":"Epothilones in development for non\u2013small-cell lung cancer: novel anti-tubulin agents with the potential to overcome taxane resistance","volume":"13","author":"Edelman","year":"2012","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.phymed.2019.152847_bib0031","first-page":"1483","article-title":"Synthesis and antitumor activity of epothilones and their analogues","volume":"10","author":"Huang","year":"2018","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.phymed.2019.152847_bib0008","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/auto.2.2.2460","article-title":"Autophagy, mitochondrial quality control, and oncogenesis","volume":"2","author":"Jin","year":"2006","journal-title":"Autophagy"},{"key":"10.1016\/j.phymed.2019.152847_bib0009","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3390\/ijms17030332","article-title":"Crosstalk between autophagy and apoptosis: potential and emerging therapeutic targets for cardiac diseases","volume":"17","author":"Li","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2019.152847_bib0010","first-page":"9333","article-title":"DNA damage regulated autophagy modulator 1 recovers the function of apoptosis-stimulating of p53 protein 2 on inducing apoptotic cell death in Huh7.5 cells","volume":"15","author":"Liu","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.phymed.2019.152847_bib0011","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.12659\/MSM.907853","article-title":"Prucalopride inhibits proliferation of ovarian cancer cells via phosphatidylinositol 3-kinase (PI3K) signaling pathway","volume":"24","author":"Liu","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.phymed.2019.152847_bib0012","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2053-6844-1-2","article-title":"Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines","volume":"1","author":"Lopez-Acevedo","year":"2014","journal-title":"Gynecol. Oncol. Res. Pract."},{"key":"10.1016\/j.phymed.2019.152847_bib0013","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.3802\/jgo.2017.28.e33","article-title":"Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas","volume":"28","author":"Miyamoto","year":"2017","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.phymed.2019.152847_bib0014","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/neuonc\/nor069","article-title":"The microtubule stabilizer patupilone (epothilone B) is a potent radiosensitizer in medulloblastoma cells","volume":"13","author":"Oehler","year":"2011","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.phymed.2019.152847_bib0032","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1126\/science.1230582","article-title":"Molecular mechanism of action of microtubule-stabilizing anticancer agents","volume":"339","author":"Prota","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.phymed.2019.152847_bib0030","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1021\/acs.jmedchem.6b00188","article-title":"Characterizing the epothilone binding site on beta-tubulin by photoaffinity labeling: identification of beta-tubulin peptides TARGSQQY and TSRGSQQY as targets of an epothilone photoprobe for polymerized tubulin","volume":"59","author":"Ranade","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phymed.2019.152847_bib0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.redox.2016.11.004","article-title":"Inhibition of autophagy with bafilomycin and chloroquine decreases mitochondrial quality and bioenergetic function in primary neurons","volume":"11","author":"Redmann","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.phymed.2019.152847_bib0016","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.lfs.2018.04.058","article-title":"Therapeutic potential of patupilone in epithelial ovarian cancer and future directions","volume":"205","author":"Rogalska","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2019.152847_bib0017","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.tiv.2012.09.006","article-title":"Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B","volume":"27","author":"Rogalska","year":"2013","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.phymed.2019.152847_bib0018","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.etap.2013.06.003","article-title":"Activation of apoptotic pathway in normal, cancer ovarian cells by epothilone B","volume":"36","author":"Rogalska","year":"2013","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152847_bib0019","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4161\/cc.9.2.10468","article-title":"Defective autophagy associated with LC3 puncta in epothilone-resistant cancer cells","volume":"9","author":"Shen","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.phymed.2019.152847_bib0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/aogs.13453","article-title":"Impact of residual disease on overall survival in patients with FIGO stage IIIB-IIIC vs. stage IV epithelial ovarian cancer after primary surgery","volume":"98","author":"Sorensen","year":"2019","journal-title":"Acta Obstet. Gynecol. Scand"},{"key":"10.1016\/j.phymed.2019.152847_bib0021","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13058-015-0662-4","article-title":"Antitumor activity of cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells","volume":"18","author":"Tanei","year":"2016","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.phymed.2019.152847_bib0022","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/med.21473","article-title":"The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: autophagy plays a role","volume":"38","author":"Thuwajit","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phymed.2019.152847_bib0023","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/onc.2012.92","article-title":"The chemotherapeutic agent paclitaxel inhibits autophagy through two distinct mechanisms that regulate apoptosis","volume":"32","author":"Veldhoen","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2019.152847_bib0024","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1080\/15384101.2015.1038685","article-title":"Autophagy and apoptosis in liver injury","volume":"14","author":"Wang","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.phymed.2019.152847_bib0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canlet.2011.03.026","article-title":"Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells","volume":"307","author":"Xi","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2019.152847_bib0026","doi-asserted-by":"crossref","first-page":"83476","DOI":"10.18632\/oncotarget.13080","article-title":"Autophagy as an emerging therapy target for ovarian carcinoma","volume":"7","author":"Zhan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2019.152847_bib0027","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1756-9966-32-99","article-title":"Suppression of autophagy enhances preferential toxicity of paclitaxel to folliculin-deficient renal cancer cells","volume":"32","author":"Zhang","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2019.152847_bib0028","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/15548627.2014.998931","article-title":"TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer","volume":"11","author":"Zhang","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.phymed.2019.152847_bib0029","first-page":"3010","article-title":"Paclitaxel inhibits the progression of cervical cancer by inhibiting autophagy via lncRNARP11-381N20.2","volume":"22","author":"Zou","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711319300194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711319300194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T04:49:58Z","timestamp":1662871798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711319300194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":33,"alternative-id":["S0944711319300194"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2019.152847","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of autophagy enhances preferential toxicity of epothilone A and epothilone B in ovarian cancer cells","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2019.152847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152847"}}